Global CD19-targeted CAR-T Cell Therapy Supply, Demand and Key Producers, 2024-2030

Page: 98

Published Date: 22 Nov 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global CD19-targeted CAR-T Cell Therapy market size is expected to reach $ 7582 million by 2030, rising at a market growth of 15.3% CAGR during the forecast period (2024-2030).

Chimeric antigen receptor (CAR) T-cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. Currently available CAR-T cell therapy products are divided into CD19 targets and BCMA targets. CD19 is the most common target. CD19 is a protein that is found on the surface of most B - cells, including malignant B - cells in certain types of leukemia and lymphoma.

This report studies the global CD19-targeted CAR-T Cell Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CD19-targeted CAR-T Cell Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CD19-targeted CAR-T Cell Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CD19-targeted CAR-T Cell Therapy total market, 2019-2030, (USD Million)
Global CD19-targeted CAR-T Cell Therapy total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CD19-targeted CAR-T Cell Therapy total market, key domestic companies, and share, (USD Million)
Global CD19-targeted CAR-T Cell Therapy revenue by player, revenue and market share 2019-2024, (USD Million)
Global CD19-targeted CAR-T Cell Therapy total market by Type, CAGR, 2019-2030, (USD Million)
Global CD19-targeted CAR-T Cell Therapy total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global CD19-targeted CAR-T Cell Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead (Yescarta&Tecartus), Novartis (Kymriah), Bristol-Myers Squibb (Breyanzi), FOSUNKite (Yescarta), Shanghai Yaoming Juno (Carteyva), Juventas, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CD19-targeted CAR-T Cell Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global CD19-targeted CAR-T Cell Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CD19-targeted CAR-T Cell Therapy Market, Segmentation by Type
Yescarta
Kymriah
Tecartus
Others

Global CD19-targeted CAR-T Cell Therapy Market, Segmentation by Application:
Lymphoma
Lymphocytic Leukemia

Companies Profiled:
Gilead (Yescarta&Tecartus)
Novartis (Kymriah)
Bristol-Myers Squibb (Breyanzi)
FOSUNKite (Yescarta)
Shanghai Yaoming Juno (Carteyva)
Juventas

Key Questions Answered
1. How big is the global CD19-targeted CAR-T Cell Therapy market?
2. What is the demand of the global CD19-targeted CAR-T Cell Therapy market?
3. What is the year over year growth of the global CD19-targeted CAR-T Cell Therapy market?
4. What is the total value of the global CD19-targeted CAR-T Cell Therapy market?
5. Who are the Major Players in the global CD19-targeted CAR-T Cell Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 CD19-targeted CAR-T Cell Therapy Introduction
    1.2 World CD19-targeted CAR-T Cell Therapy Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World CD19-targeted CAR-T Cell Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World CD19-targeted CAR-T Cell Therapy Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.3 China Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.4 Europe Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.5 Japan Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.6 South Korea Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.7 ASEAN Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
        1.3.8 India Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CD19-targeted CAR-T Cell Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.2 World CD19-targeted CAR-T Cell Therapy Consumption Value by Region
        2.2.1 World CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2019-2024)
        2.2.2 World CD19-targeted CAR-T Cell Therapy Consumption Value Forecast by Region (2025-2030)
    2.3 United States CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.4 China CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.5 Europe CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.6 Japan CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.7 South Korea CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.8 ASEAN CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)
    2.9 India CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030)

3 World CD19-targeted CAR-T Cell Therapy Companies Competitive Analysis
    3.1 World CD19-targeted CAR-T Cell Therapy Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CD19-targeted CAR-T Cell Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CD19-targeted CAR-T Cell Therapy in 2023
        3.2.3 Global Concentration Ratios (CR8) for CD19-targeted CAR-T Cell Therapy in 2023
    3.3 CD19-targeted CAR-T Cell Therapy Company Evaluation Quadrant
    3.4 CD19-targeted CAR-T Cell Therapy Market: Overall Company Footprint Analysis
        3.4.1 CD19-targeted CAR-T Cell Therapy Market: Region Footprint
        3.4.2 CD19-targeted CAR-T Cell Therapy Market: Company Product Type Footprint
        3.4.3 CD19-targeted CAR-T Cell Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: CD19-targeted CAR-T Cell Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CD19-targeted CAR-T Cell Therapy Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: CD19-targeted CAR-T Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: CD19-targeted CAR-T Cell Therapy Consumption Value Comparison
        4.2.1 United States VS China: CD19-targeted CAR-T Cell Therapy Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: CD19-targeted CAR-T Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based CD19-targeted CAR-T Cell Therapy Companies and Market Share, 2019-2024
        4.3.1 United States Based CD19-targeted CAR-T Cell Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CD19-targeted CAR-T Cell Therapy Revenue, (2019-2024)
    4.4 China Based Companies CD19-targeted CAR-T Cell Therapy Revenue and Market Share, 2019-2024
        4.4.1 China Based CD19-targeted CAR-T Cell Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CD19-targeted CAR-T Cell Therapy Revenue, (2019-2024)
    4.5 Rest of World Based CD19-targeted CAR-T Cell Therapy Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based CD19-targeted CAR-T Cell Therapy Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies CD19-targeted CAR-T Cell Therapy Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World CD19-targeted CAR-T Cell Therapy Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Yescarta
        5.2.2 Kymriah
        5.2.3 Tecartus
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World CD19-targeted CAR-T Cell Therapy Market Size by Type (2019-2024)
        5.3.2 World CD19-targeted CAR-T Cell Therapy Market Size by Type (2025-2030)
        5.3.3 World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World CD19-targeted CAR-T Cell Therapy Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Lymphoma
        6.2.2 Lymphocytic Leukemia
    6.3 Market Segment by Application
        6.3.1 World CD19-targeted CAR-T Cell Therapy Market Size by Application (2019-2024)
        6.3.2 World CD19-targeted CAR-T Cell Therapy Market Size by Application (2025-2030)
        6.3.3 World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Gilead (Yescarta&Tecartus)
        7.1.1 Gilead (Yescarta&Tecartus) Details
        7.1.2 Gilead (Yescarta&Tecartus) Major Business
        7.1.3 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product and Services
        7.1.4 Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Gilead (Yescarta&Tecartus) Recent Developments/Updates
        7.1.6 Gilead (Yescarta&Tecartus) Competitive Strengths & Weaknesses
    7.2 Novartis (Kymriah)
        7.2.1 Novartis (Kymriah) Details
        7.2.2 Novartis (Kymriah) Major Business
        7.2.3 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product and Services
        7.2.4 Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis (Kymriah) Recent Developments/Updates
        7.2.6 Novartis (Kymriah) Competitive Strengths & Weaknesses
    7.3 Bristol-Myers Squibb (Breyanzi)
        7.3.1 Bristol-Myers Squibb (Breyanzi) Details
        7.3.2 Bristol-Myers Squibb (Breyanzi) Major Business
        7.3.3 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product and Services
        7.3.4 Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Bristol-Myers Squibb (Breyanzi) Recent Developments/Updates
        7.3.6 Bristol-Myers Squibb (Breyanzi) Competitive Strengths & Weaknesses
    7.4 FOSUNKite (Yescarta)
        7.4.1 FOSUNKite (Yescarta) Details
        7.4.2 FOSUNKite (Yescarta) Major Business
        7.4.3 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product and Services
        7.4.4 FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 FOSUNKite (Yescarta) Recent Developments/Updates
        7.4.6 FOSUNKite (Yescarta) Competitive Strengths & Weaknesses
    7.5 Shanghai Yaoming Juno (Carteyva)
        7.5.1 Shanghai Yaoming Juno (Carteyva) Details
        7.5.2 Shanghai Yaoming Juno (Carteyva) Major Business
        7.5.3 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product and Services
        7.5.4 Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Shanghai Yaoming Juno (Carteyva) Recent Developments/Updates
        7.5.6 Shanghai Yaoming Juno (Carteyva) Competitive Strengths & Weaknesses
    7.6 Juventas
        7.6.1 Juventas Details
        7.6.2 Juventas Major Business
        7.6.3 Juventas CD19-targeted CAR-T Cell Therapy Product and Services
        7.6.4 Juventas CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Juventas Recent Developments/Updates
        7.6.6 Juventas Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CD19-targeted CAR-T Cell Therapy Industry Chain
    8.2 CD19-targeted CAR-T Cell Therapy Upstream Analysis
    8.3 CD19-targeted CAR-T Cell Therapy Midstream Analysis
    8.4 CD19-targeted CAR-T Cell Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World CD19-targeted CAR-T Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World CD19-targeted CAR-T Cell Therapy Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World CD19-targeted CAR-T Cell Therapy Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World CD19-targeted CAR-T Cell Therapy Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World CD19-targeted CAR-T Cell Therapy Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World CD19-targeted CAR-T Cell Therapy Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World CD19-targeted CAR-T Cell Therapy Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World CD19-targeted CAR-T Cell Therapy Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World CD19-targeted CAR-T Cell Therapy Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key CD19-targeted CAR-T Cell Therapy Players in 2023
 Table 12. World CD19-targeted CAR-T Cell Therapy Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global CD19-targeted CAR-T Cell Therapy Company Evaluation Quadrant
 Table 14. Head Office of Key CD19-targeted CAR-T Cell Therapy Players
 Table 15. CD19-targeted CAR-T Cell Therapy Market: Company Product Type Footprint
 Table 16. CD19-targeted CAR-T Cell Therapy Market: Company Product Application Footprint
 Table 17. CD19-targeted CAR-T Cell Therapy Mergers & Acquisitions Activity
 Table 18. United States VS China CD19-targeted CAR-T Cell Therapy Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China CD19-targeted CAR-T Cell Therapy Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based CD19-targeted CAR-T Cell Therapy Companies, Headquarters (States, Country)
 Table 21. United States Based Companies CD19-targeted CAR-T Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies CD19-targeted CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 23. China Based CD19-targeted CAR-T Cell Therapy Companies, Headquarters (Province, Country)
 Table 24. China Based Companies CD19-targeted CAR-T Cell Therapy Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies CD19-targeted CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 26. Rest of World Based CD19-targeted CAR-T Cell Therapy Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies CD19-targeted CAR-T Cell Therapy Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies CD19-targeted CAR-T Cell Therapy Revenue Market Share (2019-2024)
 Table 29. World CD19-targeted CAR-T Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World CD19-targeted CAR-T Cell Therapy Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World CD19-targeted CAR-T Cell Therapy Market Size by Type (2025-2030) & (USD Million)
 Table 32. World CD19-targeted CAR-T Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World CD19-targeted CAR-T Cell Therapy Market Size by Application (2019-2024) & (USD Million)
 Table 34. World CD19-targeted CAR-T Cell Therapy Market Size by Application (2025-2030) & (USD Million)
 Table 35. Gilead (Yescarta&Tecartus) Basic Information, Manufacturing Base and Competitors
 Table 36. Gilead (Yescarta&Tecartus) Major Business
 Table 37. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Product and Services
 Table 38. Gilead (Yescarta&Tecartus) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Gilead (Yescarta&Tecartus) Recent Developments/Updates
 Table 40. Gilead (Yescarta&Tecartus) Competitive Strengths & Weaknesses
 Table 41. Novartis (Kymriah) Basic Information, Manufacturing Base and Competitors
 Table 42. Novartis (Kymriah) Major Business
 Table 43. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Product and Services
 Table 44. Novartis (Kymriah) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Novartis (Kymriah) Recent Developments/Updates
 Table 46. Novartis (Kymriah) Competitive Strengths & Weaknesses
 Table 47. Bristol-Myers Squibb (Breyanzi) Basic Information, Manufacturing Base and Competitors
 Table 48. Bristol-Myers Squibb (Breyanzi) Major Business
 Table 49. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Product and Services
 Table 50. Bristol-Myers Squibb (Breyanzi) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Bristol-Myers Squibb (Breyanzi) Recent Developments/Updates
 Table 52. Bristol-Myers Squibb (Breyanzi) Competitive Strengths & Weaknesses
 Table 53. FOSUNKite (Yescarta) Basic Information, Manufacturing Base and Competitors
 Table 54. FOSUNKite (Yescarta) Major Business
 Table 55. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Product and Services
 Table 56. FOSUNKite (Yescarta) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. FOSUNKite (Yescarta) Recent Developments/Updates
 Table 58. FOSUNKite (Yescarta) Competitive Strengths & Weaknesses
 Table 59. Shanghai Yaoming Juno (Carteyva) Basic Information, Manufacturing Base and Competitors
 Table 60. Shanghai Yaoming Juno (Carteyva) Major Business
 Table 61. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Product and Services
 Table 62. Shanghai Yaoming Juno (Carteyva) CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. Shanghai Yaoming Juno (Carteyva) Recent Developments/Updates
 Table 64. Shanghai Yaoming Juno (Carteyva) Competitive Strengths & Weaknesses
 Table 65. Juventas Basic Information, Manufacturing Base and Competitors
 Table 66. Juventas Major Business
 Table 67. Juventas CD19-targeted CAR-T Cell Therapy Product and Services
 Table 68. Juventas CD19-targeted CAR-T Cell Therapy Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Juventas Recent Developments/Updates
 Table 70. Juventas Competitive Strengths & Weaknesses
 Table 71. Global Key Players of CD19-targeted CAR-T Cell Therapy Upstream (Raw Materials)
 Table 72. Global CD19-targeted CAR-T Cell Therapy Typical Customers


List of Figures
 Figure 1. CD19-targeted CAR-T Cell Therapy Picture
 Figure 2. World CD19-targeted CAR-T Cell Therapy Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World CD19-targeted CAR-T Cell Therapy Total Revenue (2019-2030) & (USD Million)
 Figure 4. World CD19-targeted CAR-T Cell Therapy Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World CD19-targeted CAR-T Cell Therapy Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company CD19-targeted CAR-T Cell Therapy Revenue (2019-2030) & (USD Million)
 Figure 13. CD19-targeted CAR-T Cell Therapy Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 16. World CD19-targeted CAR-T Cell Therapy Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 18. China CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 23. India CD19-targeted CAR-T Cell Therapy Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of CD19-targeted CAR-T Cell Therapy by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for CD19-targeted CAR-T Cell Therapy Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for CD19-targeted CAR-T Cell Therapy Markets in 2023
 Figure 27. United States VS China: CD19-targeted CAR-T Cell Therapy Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: CD19-targeted CAR-T Cell Therapy Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World CD19-targeted CAR-T Cell Therapy Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Type in 2023
 Figure 31. Yescarta
 Figure 32. Kymriah
 Figure 33. Tecartus
 Figure 34. Others
 Figure 35. World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Type (2019-2030)
 Figure 36. World CD19-targeted CAR-T Cell Therapy Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Application in 2023
 Figure 38. Lymphoma
 Figure 39. Lymphocytic Leukemia
 Figure 40. World CD19-targeted CAR-T Cell Therapy Market Size Market Share by Application (2019-2030)
 Figure 41. CD19-targeted CAR-T Cell Therapy Industrial Chain
 Figure 42. Methodology
 Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Gilead (Yescarta&Tecartus)
Novartis (Kymriah)
Bristol-Myers Squibb (Breyanzi)
FOSUNKite (Yescarta)
Shanghai Yaoming Juno (Carteyva)
Juventas

Related Reports

Global CD19-targeted CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CD19-targeted CAR-T Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 22 Nov 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global CD19-targeted CAR-T Cell Therapy market size was valued at US$ 2847 million in 2023 and is forecast to a readjusted size of USD 7582 million by 2030 with a CAGR of 15.3% during review period.

Product Tags

CD19-targeted CAR-T Cell Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>